4//SEC Filing
Van Naarden Jacob 4
Accession 0000059478-23-000065
CIK 0000059478other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:07 PM ET
Size
7.0 KB
Accession
0000059478-23-000065
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
- Award
Common Stock
2023-02-10$345.12/sh+2,407$830,704→ 10,374 total
Holdings
- 4,342(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001661254
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:07 PM ET
- Size
- 7.0 KB